Tinnitus

Texas Roadhouse and Bubba's 33 Shatter Fundraising and Awareness Goals to Benefit the American Tinnitus Association and Its Mission to Transform Tinnitus Care

Retrieved on: 
Thursday, February 29, 2024

The charitable event, held in memory of Texas Roadhouse founder Kent Taylor, who had severe tinnitus, raised $925,000 for ATA.

Key Points: 
  • The charitable event, held in memory of Texas Roadhouse founder Kent Taylor, who had severe tinnitus, raised $925,000 for ATA.
  • Texas Roadhouse and Bubba's 33 are committed to raising awareness of tinnitus because of Kent's experience and the reality that few people consider tinnitus and its varied effects until they are affected by it.
  • "We are proud to partner with ATA to raise money and bring attention to tinnitus.
  • Texas Roadhouse and Bubba's 33 are helping to ensure that ATA can deliver on its mission to educate the public and healthcare professionals," she said.

American Tinnitus Association Calls for Proposals: Innovative Tinnitus Research Grant Application Now Available

Retrieved on: 
Friday, February 2, 2024

VIENNA, Va., Feb. 2, 2024 /PRNewswire/ -- The American Tinnitus Association (ATA), the nation's leading non-profit dedicated exclusively to serving the needs of the tinnitus community, is pleased to announce the opening of applications for its 2024 Innovative Research Grants Program.

Key Points: 
  • VIENNA, Va., Feb. 2, 2024 /PRNewswire/ -- The American Tinnitus Association (ATA), the nation's leading non-profit dedicated exclusively to serving the needs of the tinnitus community, is pleased to announce the opening of applications for its 2024 Innovative Research Grants Program.
  • ATA offers seed grant funding for research investigating tinnitus interventions ranging from therapy using drugs and supplements to those that employ sound and counseling.
  • Funding is available for new investigators trying to build a tinnitus research program as well as established research teams with an emerging interest in tinnitus.
  • ATA is accepting innovative tinnitus research proposals from now until April 26, 2024.

Lindus Health Introduces Bespoke "All-In-One CRO for Digital Therapeutics" Solution to Companies in the Space Streamline Clinical Trials

Retrieved on: 
Thursday, February 1, 2024

Lindus Health's new offering for the DTx market bundles the services of an experienced CRO in DTx.

Key Points: 
  • Lindus Health's new offering for the DTx market bundles the services of an experienced CRO in DTx.
  • This offering is intended to produce a true "one-stop-shop" experience for everything needed to run a DTx clinical trial.
  • Technology-driven recruitment services: Lindus Health employs a variety of different strategies to accelerate DTx trials.
  • Lindus Health's "All-In-One CRO" offering enables DTx companies to achieve study milestones faster through their tech-forward and patient-centric approach to executing clinical trials.

Third Annual Nationwide Texas Roadhouse and Bubba's 33 Tinnitus Awareness Fundraiser to Benefit the American Tinnitus Association

Retrieved on: 
Thursday, January 18, 2024

VIENNA, Va., Jan. 17, 2024 /PRNewswire/ -- Tinnitus Awareness Week is observed the first full week of February with the purpose of educating the public about the symptoms of tinnitus and how it affects people. In a united effort to raise awareness of the condition and its prevention during Tinnitus Awareness Week, Texas Roadhouse and its affiliate, Bubba's 33, along with the American Tinnitus Association (ATA), are proud to announce a national tinnitus fundraiser and awareness event on February 5. This is the third year that the family of Texas Roadhouse and Bubba's 33 restaurants have hosted the event to raise funds for ATA. The February 5 event pays tribute to their late founder, Kent Taylor, who struggled with tinnitus.

Key Points: 
  • Profits on February 5 will be donated to the American Tinnitus Association to honor Texas Roadhouse founder, Kent Taylor, and to help those living with tinnitus.
  • In a united effort to raise awareness of the condition and its prevention during Tinnitus Awareness Week, Texas Roadhouse and its affiliate, Bubba's 33, along with the American Tinnitus Association (ATA), are proud to announce a national tinnitus fundraiser and awareness event on February 5.
  • For Texas Roadhouse and Bubba's 33, raising awareness of tinnitus is deeply personal.
  • Through its partnership with Texas Roadhouse and Bubba's 33 to raise awareness of tinnitus, ATA can connect with people who've never considered tinnitus or encountered anyone living with severe tinnitus.

MindEar’s Evidence-based Smartphone App is Changing the Lives of Those Affected by Tinnitus

Retrieved on: 
Tuesday, January 9, 2024

The research team from Australia, New Zealand, France and Belgium report these findings today in Frontiers in Audiology and Otology .

Key Points: 
  • The research team from Australia, New Zealand, France and Belgium report these findings today in Frontiers in Audiology and Otology .
  • It offers hope for millions affected by tinnitus who:
    face long wait times for treatment, or
    can’t afford the costs of specialist support.
  • The team is now planning larger trials in the UK in collaboration with the University College London Hospital.
  • The app, MindEar, is available on the iOS App Store and Google Play.

scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX® Revenue

Retrieved on: 
Thursday, January 4, 2024

BURLINGTON, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced preliminary unaudited fourth quarter 2023 net FUROSCIX revenue in a range of $5.9 million to $6.1 million, representing sequential growth of 55% to 61% over $3.8 million net FUROSCIX revenue reported for the third quarter of 2023.

Key Points: 
  • For the full year 2023, the Company anticipates net revenue to be in a range of $13.4 million to $13.6 million.
  • The gross-to-net discount decreased to approximately 18% from launch through the end of Q4 versus 21% from launch through the end of Q3.
  • Inventory levels at the end of Q4 2023 were consistent with levels at the end of Q3 2023.
  • scPharmaceuticals will report its final and complete fourth quarter and full-year 2023 financial results in March.

Altamira Therapeutics Provides Investor and Business Update

Retrieved on: 
Monday, December 11, 2023

HAMILTON, BERMUDA, Dec. 11, 2023 -- Altamira Therapeutics Ltd. (Nasdaq: CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs, today provided an investor and business update highlighting recent activities and milestones achieved following the Company’s partial spin-off of its Bentrio® business and pivot towards becoming a pure-play RNA delivery business.

Key Points: 
  • Company hosts Investor and Business Update call on December 11 at 8:30 a.m.
  • ET
    HAMILTON, BERMUDA, Dec. 11, 2023 -- Altamira Therapeutics Ltd. (Nasdaq: CYTO) ("Altamira" or the "Company"), a company dedicated to addressing unmet medical needs, today provided an investor and business update highlighting recent activities and milestones achieved following the Company’s partial spin-off of its Bentrio® business and pivot towards becoming a pure-play RNA delivery business.
  • Meanwhile, Altamira is also pursuing the partnering of its other legacy assets, which include several development programs in inner ear therapeutics.
  • ET to discuss its investor and business update.

Neurostimulation Technology and Global Markets Report 2023: 2020-2022 Data, Estimates for 2023, and CAGR Projections through 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 20, 2023

This report provides a comprehensive study of the global market for neurostimulation technologies and devices.

Key Points: 
  • This report provides a comprehensive study of the global market for neurostimulation technologies and devices.
  • It provides a detailed description of the different types of neurostimulation technologies and devices (invasive and noninvasive) and their current and historical market revenues.
  • Currently, the potential of neurostimulation technology is actively being explored for other clinical conditions including obesity, tinnitus and central nerve system disorders.
  • An in-depth analysis of the global market for neurostimulation technologies and devices includes historical data and market projections by device type, therapeutic application and region.

Special holiday gift: Building Homes for Heroes donates home to retired Marine, Purple Heart recipient and grandson of Navajo Code Talker

Retrieved on: 
Wednesday, December 6, 2023

ALBUQUERQUE, N.M., Dec. 6, 2023 /PRNewswire/ -- The national nonprofit Building Homes for Heroes gifted a mortgage-free home today to retired Marine Sgt.

Key Points: 
  • ALBUQUERQUE, N.M., Dec. 6, 2023 /PRNewswire/ -- The national nonprofit Building Homes for Heroes gifted a mortgage-free home today to retired Marine Sgt.
  • Dustin Francisco, a Purple Heart recipient and grandson of a Navajo Code Talker, in a spirit of gratitude this holiday season.
  • Bedecked in a holiday theme, the 1,890-square-foot home, donated by JPMorgan Chase to Building Homes for Heroes, was gifted to Francisco, his partner, Kimberlyn Tom, and four children.
  • "It's a symbol of hope, healing and the unwavering support of organizations like Building Homes for Heroes.

GN and Soundly Presents "Inside the Ear", Digital Art Campaign Aiming to Transform Hearing Health Awareness

Retrieved on: 
Thursday, November 30, 2023

BALLERUP, Denmark, Nov. 30, 2023 /PRNewswire/ -- GN, the global leader in hearing aid innovation, and Soundly, a consumer education resource for hearing wellness, have joined forces once again to present "Inside the Ear," a digital art campaign aimed at demystifying hearing loss and hearing health. The campaign, launching today, showcases a series of fascinating and educational videos created by award-winning digital artist, Design Cells, which beautifully illustrate the complex inner workings of the ear.

Key Points: 
  • The campaign explores the inner workings of the ear through vibrant visuals, empowering consumers with a deeper understanding of their hearing health.
  • BALLERUP, Denmark, Nov. 30, 2023 /PRNewswire/ -- GN, the global leader in hearing aid innovation, and Soundly, a consumer education resource for hearing wellness, have joined forces once again to present "Inside the Ear," a digital art campaign aimed at demystifying hearing loss and hearing health.
  • GN and Soundly unite with a shared vision to cultivate greater awareness and education surrounding the crucial significance of maintaining optimal hearing health.
  • Explore the complete "Inside the Ear" digital art collection and delve into the significance of hearing health by clicking here .